[1] Ritchie A, Kramer JM.Recent advances in the etiology and treatment of burning mouth syndrome[J]. J Dent Res, 2018, 97(11): 1193-1199. [2] Jääskeläinen SK.Pathophysiology of primary burning mouth syndrome[J]. Clin Neurophysiol, 2012, 123(1): 71-77. [3] Adamo D, Celentano A, Ruoppo E, et al.The relationship between sociodemographic characteristics and clinical features in burning mouth syndrome[J]. Pain Med, 2015, 16(11): 2171-2179. [4] Headache Classification Committee of the International Headache Society(IHS). The International Classification of Headache Disorders, 3rd edition[J]. Cephalalgia, 2018, 38(1): 1-211. [5] Lopez-jornet P, Molino-pagan D, Parra-perez P, et al. Neuropathic pain in patients with burning mouth syndrome evaluated using painDETECT[J]. Pain Med, 2017, 18(8): 1528-1533. [6] Pereira SR, Tello Velasquez J, Duggan S, et al.Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: focus on the actions of cannabinoids[J]. Eur J Neurosci, 2022, 55(4): 1032-1050. [7] Erbas GS, Botsali A, Erden N, et al.COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review[J]. Int J Dermatol, 2022, 61(1): 20-32. [8] Farid H, Khan M, Jamal S, et al.Oral manifestations of Covid-19-a literature review[J]. Rev Med Virol, 2022, 32(1): e2248. [9] Maeda C, Watanebe M, Tu TTH, et al.Psychiatric comorbidities in chronic orofacial pain during COVID-19 pandemic[J]. J Psychosom Res, 2023, 172: 111420. [10] Berglundh T, Armitage G, Araujo MG, et al.Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions[J]. J Clin Periodontol, 2018, 45(Suppl 20): S286-S291. [11] Moutsopoulos NM, Kling HM, Angelov N, et al.Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis[J]. J Autoimmun, 2012, 39(4): 294-303. [12] Barry A, O'halloran KD, Mckenna JP, et al. Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: results from a pilot study[J]. J Oral Pathol Med, 2018, 47(2): 158-165. [13] Miyauchi T, Tokura T, Kimura H, et al.Effect of antidepressant treatment on plasma levels of neuroinflammation-associated molecules in patients with somatic symptom disorder with predominant pain around the orofacial region[J]. Hum Psychopharmacol, 2019, 34(4): e2698. [14] Fischer RG, Lira Junior R, Retamal-valdes B, et al. Periodontal disease and its impact on general health in Latin America. section V: treatment of periodontitis[J]. Braz Oral Res, 2020, 34(suppl 1): e026. [15] Kishore J, Shaikh F, Zubairi AM, et al.Evaluation of serum neuron specific enolase levels among patients with primary and secondary burning mouth syndrome[J]. Cephalalgia, 2022, 42(2): 119-127. [16] Matsuoka H, Himachi M, Furukawa H, et al.Cognitive profile of patients with burning mouth syndrome in the Japanese population[J]. Odontology, 2010, 98(2): 160-164. [17] Lee SJ, Kim C, Yu H, et al.Relationship of depression, anxiety, and bipolar disease with burning mouth syndrome: a nationwide cohort study[J]. Int J Environ Res Public Health, 2023, 20(4): 3391. [18] Fang M, Huang Y, Li C, et al.The over-expression of miRNA-206 in peripheral blood of patients with burning mouth syndrome and its relationship with anxiety and depression[J]. J Oral Rehabil, 2023, 50(4): 324-331. [19] Fiksdal A, Hanlin L, Kuras Y, et al.Associations between symptoms of depression and anxiety and cortisol responses to and recovery from acute stress[J]. Psychoneuroendocrinology, 2019, 102: 44-52. [20] Chronister BN, Gonzalez E, Lopez-paredes D, et al. Testosterone, estradiol, DHEA and cortisol in relation to anxiety and depression scores in adolescents[J]. J Affect Disord, 2021, 294: 838-846. [21] Ikuta K, Ejima A, Abe S, et al.Control of immunity and allergy by steroid hormones[J]. Allergol Int, 2022, 71(4): 432-436. [22] Gurvits GE, Tan A.Burning mouth syndrome[J]. World J Gastroenterol, 2013, 19(5): 665-672. [23] Santoro V, Caputo G, Peluso F.Clinical and therapeutic experience in twenty eight patients with burning mouth syndrome[J]. Minerva Stomatol, 2005, 54(9): 489-496. [24] Dibello V, Ballini A, Lozupone M, et al.Exploring the association of burning mouth syndrome with depressive and anxiety disorders in middle-aged and older adults: a systematic review[J]. J Pers Med, 2023, 13(6): 1014. [25] Clarke L, Chisholm K, Cappuccio FP, et al.Sleep disturbances and the at risk mental state: a systematic review and meta-analysis[J]. Schizophr Res, 2021, 227: 81-91. [26] Geoffroy PA, Tebeka S, Blanco C, et al.Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: findings from a nationally representative survey of US adults (NESARC-III)[J]. J Psychiatr Res, 2020, 124: 34-41. [27] Salari N, Khazaie H, Hosseinian-far A, et al. The prevalence of sleep disturbances among physicians and nurses facing the COVID-19 patients: a systematic review and meta-analysis[J]. Global Health, 2020, 16(1): 92. [28] Lee GS, Kim HK, Kim ME.Relevance of sleep, pain cognition, and psychological distress with regard to pain in patients with burning mouth syndrome[J]. Cranio, 2022, 40(1): 79-87. [29] Biadsee A, Biadsee A, Kassem F, et al.Olfactory and oral manifestations of COVID-19: sex-related symptoms-a potential pathway to early diagnosis[J]. Otolaryngol Head Neck Surg, 2020, 163(4): 722-728. [30] Lechien JR, Chiesa-Estomba CM, De Siati DR, et al.Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study[J]. Eur Arch Otorhinolaryngol, 2020, 277(8): 2251-2261. [31] Puhakka A, Forssell H, Soinila S, et al.Peripheral nervous system involvement in primary burning mouth syndrome-results of a pilot study[J]. Oral Dis, 2016, 22(4): 338-344. [32] Braud A, Descroix V, Ungeheuer MN, et al.Taste function assessed by electrogustometry in burning mouth syndrome: a case-control study[J]. Oral Dis, 2017, 23(3): 395-402. [33] Sinjari B, D'ardes D, Santilli M, et al. SARS-CoV-2 and oral manifestation: an observational, human study[J]. J Clin Med, 2020, 9(10): 3218. [34] Iranmanesh B, Khalili M, Amiri R, et al.Oral manifestations of COVID-19 disease: a review article[J]. Dermatol Ther, 2021, 34(1): e14578. [35] Soung AL, Vanderheiden A, Nordvig AS, et al.COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis[J]. Brain, 2022, 145(12): 4193-4201. [36] Wu YH, Chiang CP.Association of medications with burning mouth syndrome in Taiwanese aged patients[J]. J Dent Sci, 2023, 18(2): 833-839. [37] Lechien JR, Hans S, De Marrez LG, et al.Prevalence and features of laryngopharyngeal reflux in patients with primary burning mouth syndrome[J]. Laryngoscope, 2021, 131(10): E2627-E2633. [38] 李军祥, 陈誩, 冯五金, 等. 消化心身疾病中西医结合整体诊治专家指导意见(2017年)[J]. 中国中西医结合消化杂志, 2018, 26(1): 9-17. [39] 姜巍, 周剑杰, 程寒, 等. 基于干细胞因子(SCF)/c-kit信号通路探讨和胃理气方治疗功能性消化不良胃肠运动功能障碍的作用机制[J]. 广州中医药大学学报, 2021, 38(4): 766-773. [40] Russo M, Crafa P, Guglielmetti S, et al.Burning mouth syndrome etiology: a narrative review[J]. J Gastrointestin Liver Dis, 2022, 31(2): 223-228. [41] Ikenouchi H, Yoshimoto T, Ihara M.Postprandial cerebral infarction[J]. J Clin Neurosci, 2021, 94: 38-40. [42] Lee YC, Jahng GH, Ryu CW, et al.Change in gray matter volume and cerebral blood flow in patients with burning mouth syndrome[J]. J Oral Pathol Med, 2019, 48(4): 335-342. [43] Guo J, Wang J, Sun W, et al.The advances of post-stroke depression: 2021 update[J]. J Neurol, 2022, 269(3): 1236-1249. [44] Zhou L, Wang T, Yu Y, et al.The etiology of poststroke-depression: a hypothesis involving HPA axis[J]. Biomed Pharmacother, 2022, 151: 113146. |